Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.
3.

Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.

Black SB, Shinefield HR, Lampert D, Fireman B, Hiatt RA, Polen M, Vittinghoff E.

Pediatr Infect Dis J. 1991 Feb;10(2):92-6.

PMID:
2062620
[PubMed - indexed for MEDLINE]
4.

Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster.

Booy R, Heath PT, Slack MP, Begg N, Moxon ER.

Lancet. 1997 Apr 26;349(9060):1197-202. Erratum in: Lancet 1997 May 31;349(9065):1630.

PMID:
9130940
[PubMed - indexed for MEDLINE]
5.

Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy.

Peltola H, Eskola J, Käyhty H, Takala AK, Mäkelä PH.

Arch Pediatr Adolesc Med. 1994 Jun;148(6):620-5.

PMID:
8193690
[PubMed - indexed for MEDLINE]
6.
8.

Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy. The Kaiser Permanente Pediatric Vaccine Study Group.

Black SB, Shinefield HR, Ray P, Lewis EM, Fireman B, Hiatt R, Madore DV, Johnson CL, Hackell JG.

Pediatr Infect Dis J. 1993 Dec;12(12):981-5.

PMID:
8108224
[PubMed - indexed for MEDLINE]
9.

The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.

Santosham M, Wolff M, Reid R, Hohenboken M, Bateman M, Goepp J, Cortese M, Sack D, Hill J, Newcomer W, et al.

N Engl J Med. 1991 Jun 20;324(25):1767-72.

PMID:
1903846
[PubMed - indexed for MEDLINE]
Free Article
10.

Protection provided by Haemophilus influenzae type b conjugate vaccines in Los Angeles County: a case-control study.

Vadheim CM, Greenberg DP, Eriksen E, Hemenway L, Christenson P, Ward B, Mascola L, Ward JI.

Pediatr Infect Dis J. 1994 Apr;13(4):274-80.

PMID:
8036043
[PubMed - indexed for MEDLINE]
11.

Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine.

Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM.

J Pediatr. 1993 Apr;122(4):517-23.

PMID:
8463894
[PubMed - indexed for MEDLINE]
12.

Cost-benefit analysis of Haemophilus influenzae type b prevention: conjugate vaccination at eighteen months of age.

Hay JW, Daum RS.

Pediatr Infect Dis J. 1990 Apr;9(4):246-52.

PMID:
2110651
[PubMed - indexed for MEDLINE]
13.

Finnish efficacy trials with Haemophilus influenzae type b vaccines.

Eskola J, Peltola H, Käyhty H, Takala AK, Mäkelä PH.

J Infect Dis. 1992 Jun;165 Suppl 1:S137-8. Review.

PMID:
1588148
[PubMed - indexed for MEDLINE]
14.

Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohort.

Black SB, Lewis E, Shinefield HR, Fireman B, Ray P, DeStefano F, Chen R.

Pediatr Infect Dis J. 2002 Jun;21(6):568-9.

PMID:
12182385
[PubMed - indexed for MEDLINE]
15.

Immunogenicity of Haemophilus influenzae-diphtheria CRM197 protein conjugate vaccine (HbOC) in Libyan infants.

Hadida M, Cuevas LE, Moghadami A, Baccoosh M, Gurgel RQ, Hart CA.

Trop Med Int Health. 1998 Feb;3(2):95-9.

PMID:
9537270
[PubMed - indexed for MEDLINE]
Free Article
16.

Efficacy of Haemophilus influenzae type b capsular polysaccharide vaccine.

Black SB, Shinefield HR, Hiatt RA, Fireman BH.

Pediatr Infect Dis J. 1988 Mar;7(3):149-56.

PMID:
3258659
[PubMed - indexed for MEDLINE]
17.

Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.

Sood SK, Daum RS.

Pediatrics. 1990 Apr;85(4 Pt 2):698-704. Review.

PMID:
2107522
[PubMed - indexed for MEDLINE]
18.

Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.

Yogev R, Arditi M, Chadwick EG, Amer MD, Sroka PA.

Pediatrics. 1990 Apr;85(4 Pt 2):690-3.

PMID:
2107520
[PubMed - indexed for MEDLINE]
19.

Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine.

Barbour ML, Booy R, Crook DW, Griffiths H, Chapel HM, Moxon ER, Mayon-White D.

Pediatr Infect Dis J. 1993 Jun;12(6):478-84.

PMID:
8345980
[PubMed - indexed for MEDLINE]
20.

Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants.

Bulkow LR, Wainwright RB, Letson GW, Chang SJ, Ward JI.

Pediatr Infect Dis J. 1993 Jun;12(6):484-92.

PMID:
8345981
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk